Modulation of SIRT1/AMPK and Akt/mTOR pathways is crucial in reducing insulin levels, insulin resistance, glucotoxicity and lipotoxicity, and in increasing ketogenesis (60). The gene discussed is AKT1; the disease is Insulin resistance.